Standigm

📍 Seoul, South Korea🗓 Founded 2015👥 31 employees💰 Last funded Nov 2019
Pharmaceutical Manufacturing🌐 standigm.com
Website LinkedIn
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing. Learn more at http://www.standigm.com.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
South Korea
2
Korea
1
Investor activity2015–2019 · investors recorded per year
2015120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Standigm?
Standigm has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Standigm last raise funding?
The most recent investment in Standigm recorded on gritt.io was in November 2019.
When was Standigm founded?
Standigm was founded in 2015.
What industry is Standigm in?
Standigm operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Standigm based?
Standigm is headquartered in Seoul, South Korea.